| prov:value
| - Any additional markers that are identified as being unique to or increased upon cancer cells, such as leukemias, are also included within the scope of the methods, devices, and systems described herein. [0242] Other cancer antigens useful within the scope of the methods, devices, and systems described herein, include, for example PSA, Her-2, Mic-1, CEA, PSMA, mini-MUC, MUC-I, HER2 receptor, mammog
|